Deleting redox: Acids, sulfones and hydrazides

Redox-active esters turned carboxylic acids into coupling partners. Redox-active sulfones did the same for a different everyday handle. Sulfonyl hydrazides went a step further: the reagent itself supplies the electron.

7 chapters ~18 min read 4 films 11 key papers
Three rocket engines labelled Generation 1, 2 and 3 of radical cross-coupling: redox-mediated, canonical redox-neutral, and redox-neutral with sulfonyl hydrazides.
Three generations of radical cross-coupling, pictured as rocket engines. Graphical abstract, Neigenfind, Kawamata & Baran, ChemRxiv 2026 (CC BY 4.0).
Milestones

Timeline

  1. 2016

    A name for an old ester

    “Redox-active” esters defined: HOAt, HOBt and NHPI esters accept an electron from nickel, in the dark.

    See the paper →
  2. 2016

    Redox-active esters

    Carboxylic acids become coupling partners via Ni catalysis; >70 alkyl–alkyl examples.

    See the paper →
  3. 2016

    Iron joins nickel

    First Fe-catalyzed couplings of redox-active esters with organozinc and Grignard reagents.

    See the paper →
  4. 2017

    Decarboxylative borylation

    Acids to boronic acids; Velcade, Ninlaro and a boronic vancomycin.

    See the paper →
  5. 2017

    Barton, revisited

    Barton esters shown to be redox-active; Ni-catalyzed Barton decarboxylation and Giese reactions without light.

    See the paper →
  6. 2018

    Sulfones

    Modular radical cross-coupling with sulfones for sp³-rich fluoroalkyl groups.

    See the paper →
  7. 2018

    Copper

    Cu-catalyzed decarboxylative borylation of redox-active esters.

    See the paper →
  8. 2021

    Vividion acquired

    Bayer acquires Vividion, co-founded by Baran, Cravatt and Yu, for $1.5 billion upfront plus up to $500 million in milestones.

  9. 2022

    Electrochemical dDCC

    Two carboxylic acids coupled to each other with Ni-electrocatalysis.

    See the paper →
  10. 2025

    Sulfonyl hydrazides

    A general redox-neutral platform: the reagent supplies its own electron.

    See the paper →
  11. 2025

    Stereoretention

    First radical cross-couplings that keep a stereocentre, up to 96% es.

    See the paper →
  12. 2026

    C-glycosides

    Unprotected sugars coupled directly; gliflozins in one step.

    See the paper →
  13. 2026

    Deleting Redox

    The review that maps the whole spectrum.

    See the paper →
Scroll sideways for more →
01 The breakthrough

A carboxylic acid becomes a coupling partner

The most abundant handle in the chemist’s catalogue is the carboxylic acid. In 2016 the lab showed that it could be turned into a radical source with the same kind of activation chemists already use to make amide bonds.

The trick was a redox-active ester (RAE): the acid is converted to an N-hydroxyphthalimide-type ester, a nickel catalyst passes it one electron, carbon dioxide is lost and an alkyl radical is released and coupled. In JACS 2016 the partner was an aryl zinc reagent and the catalyst was inexpensive NiCl₂·6H₂O. In Science the same year it became a general alkyl–alkyl coupling with more than 70 examples, which the authors framed by direct analogy to amide synthesis: one forms a bond with loss of water, the other with loss of CO₂.

Two equations: a carboxylic acid plus an amine gives an amide with loss of water; a carboxylic acid plus an alkylzinc reagent gives a carbon–carbon bond with loss of carbon dioxide.
The analogy at the heart of the 2016 Science paper: treat a C–C bond like an amide bond. Activate the acid, add the partner, lose a small molecule.Diagram: Baran Lab website, after Qin et al., Science 2016.
Posted the day the Science paper appeared. Phil sets up the reaction himself, at the bench, to show how ordinary it is: the same acid can be taken on to an amide or, with a nickel catalyst and a zinc reagent, to a new C–C bond. Baran Lab · 21 Apr 2016 · Watch on YouTube ↗

The idea spread fast. Within a year the same activated acids were being converted into boronic acids (Science 2017), used to make boron-containing drugs such as Velcade and Ninlaro and a boronic acid version of vancomycin, and coupled to alkenes (Nature 2017). Iron catalysis (JACS 2016) and, later, electrochemistry joined nickel.

Released alongside the Science paper on decarboxylative borylation (Antony W. Yu is a co-author). Baran Lab · 13 Apr 2017 · Watch on YouTube ↗

By 2022 there was enough to take stock. In an Innovations article for ACS Medicinal Chemistry Letters, written with Gabriele Laudadio, Max Palkowitz and Tamara El-Hayek Ewing (ACS Med. Chem. Lett. 2022), the lab described the carboxylic acid as the most versatile and ubiquitous diversity input in medicinal chemistry, the everyday partner of amide synthesis, and asked what happens when the same acid is sent down a one-electron path instead. Three distinct catalytic manifolds are available: a redox-active ester coupled with an organometallic nucleophile; a redox-active ester coupled with an aryl or vinyl halide, with a chemical, photochemical or electrochemical reductant supplying the electrons; or the free acid oxidized directly by an excited photocatalyst. Each has blind spots, so the article lays them side by side in a colour-coded functional-group “user guide” that a chemist can consult before choosing conditions.

The case studies are the persuasive part, each a well-trodden polar route set against its radical counterpart. A C-3-arylated N-Boc morpholine that took eight steps, with the arene fixed at the outset, becomes a single coupling of a commercially available acid-bearing heterocycle (JACS 2022). A twelve-step route to the antipsychotic asenapine, which calls for strong base, diazomethane and osmium, gives way to a cycloaddition followed by two consecutive decarboxylative couplings, eight steps in all (Nature 2018). Where a Suzuki coupling followed by hydrogenation often requires three separate uses of palladium, a single nickel catalyst forges the key bond at the correct oxidation state. And with doubly decarboxylative coupling (Nature 2022), an unnatural amino acid once made in eight steps, without forming a single C–C bond, is reached in one step from two commercially available acids as its methyl ester.

The article is also candid about the limits. Polar chemistry has had nearly a century of refinement and will likely always remain a powerful way to build carbon–carbon bonds; in surveys of the reactions most used in pharmaceutical chemistry, radical reactions are nowhere to be found, a legacy of the long-held view that radicals are hard to tame. Its closing thought is a hope rather than a claim:

“In reflecting on the cutting-edge nature of amide-bond formation in the 1950s and its status today as perhaps the most used reaction of our time, one wonders if radical cross-coupling methods in 2050 will be viewed as commonplace and, perhaps, even boring.”

— Laudadio, Palkowitz, El-Hayek Ewing & Baran, “Decarboxylative Cross-Coupling: A Radical Tool in Medicinal Chemistry,” ACS Med. Chem. Lett. 2022

That is the ambition in a sentence. The two-electron chemistry of a carboxylic acid, activate it and add an amine, is so routine that nobody thinks twice about it. The hope is that its one-electron chemistry, activate it and add a nickel catalyst, becomes just as unremarkable: a reaction a medicinal chemist reaches for without ceremony. Why the lab counts that as the highest compliment is the subject of “Boring reactions, on purpose” below.

Graphical abstract: Decarboxylative Cross-Coupling: A Radical Tool in Medicinal Chemistry
Decarboxylative cross-coupling as a radical tool in medicinal chemistry (ACS Med. Chem. Lett. 2022): carboxylic acids, the workhorse of amide synthesis, put to work making C–C bonds. Graphical abstract from Decarboxylative Cross-Coupling: A Radical Tool in Medicinal Chemistry, ACS Med. Chem. Lett. 2022 · doi:10.1021/acsmedchemlett.2c00286
⚗ For chemists

Why carboxylic acids?

Acids are cheap, stable, sold in enormous variety, and already present in amino acids, natural products and drug intermediates. Activating them as RAEs (NHPI or the tetrachloro TCNHPI esters) uses the same coupling agents as amide synthesis, and the ester can often be made in situ. As the 2022 ACS Med. Chem. Lett. article puts it, “operationally these reactions are akin to amide-bond formation.”

Graphical abstract: A General Alkyl-Alkyl Cross-Coupling Enabled by Redox-Active Esters and Alkylzinc Reagents
A general alkyl–alkyl cross-coupling enabled by redox-active esters and alkylzinc reagents (Science 2016). Graphical abstract from A General Alkyl-Alkyl Cross-Coupling Enabled by Redox-Active Esters and Alkylzinc Reagents, Science 2016 · doi:10.1126/science.aaf6123
02 The vocabulary

A name for an old ester

Some discoveries add a reaction to chemistry. Rarer ones add a word. In February 2016 a short communication gave a family of very ordinary esters a new name, and the name has been doing work ever since.

The esters were not new. Chemists had been making them for decades to build amide bonds: HOBt and HOAt esters were the workhorses of peptide coupling, and N-hydroxyphthalimide (NHPI) esters were cheap, crystalline and stable on the shelf. Radical chemists knew some of these molecules too. Derek Barton’s thiohydroxamate esters, introduced in 1983, released alkyl radicals when light or a radical chain broke them apart. In 1988 Okada, Okamoto and Oda showed that an NHPI ester could take an electron from a light-excited sensitizer, lose carbon dioxide and give a radical (J. Am. Chem. Soc. 1988; extended to Michael additions in 1991). For almost three decades that photoinduced electron transfer stayed a specialist’s tool, and nobody gave the class a name.

The name arrived by accident. The lab was trying to intercept a classic Barton decarboxylation with a nickel–aryl complex. Under visible light the coupled product formed in 51% yield. In the dark, at room temperature, it still formed in 54%. Light was not needed: the nickel complex itself was passing an electron to the ester. In J. Am. Chem. Soc. 2016, written with chemists at Bristol-Myers Squibb, Cornella, Edwards, Qin and colleagues followed that clue and drew a new boundary around a familiar set of molecules.

“For the purpose of this study, ‘redox-active’ esters are defined as those which can accept an electron (to form a radical anion …) and gracefully depart as a stable and unreactive anion.”

Then they tested the definition on the shelf of the peptide chemist. The Barton ester worked, but it was impractical and gave by-products. An acid chloride and a methyl ester gave nothing. The classic HOAt and HOBt esters gave good yields, a property the paper called “the underappreciated ability of such redox-active esters to readily accept an electron.” A pentafluorophenyl ester and an NHS ester failed. The best balance of reactivity, stability and price was the NHPI ester, made from a reagent costing about $19.50 a mole and coupled with NiCl₂·6H₂O at about $9.50 a mole. Activate the acid as you would for an amide, add nickel and an arylzinc reagent, and carbon dioxide leaves.

Within months the term was in the titles of three more of the lab’s papers. Science 2016 put it in its title, alkyl–alkyl coupling “enabled by redox-active esters,” and spelled out the family: HOAt, HOBt, NHPI and TCNHPI esters “are termed redox-active.” Angewandte 2016 coupled redox-active esters with boronic acids. J. Am. Chem. Soc. 2016 showed the first couplings of redox-active esters with iron, comparing it side by side with nickel across more than 40 examples, and noted that many amide-coupling esters “can function as ‘redox-active’ esters.” The circle closed with Barton’s own esters. The Ni-catalyzed Barton decarboxylation and Giese reactions opened with the lab’s realization, from work begun in 2015, “that Barton esters … are redox-active species which readily accept electrons from metal complexes through a purely thermal single electron transfer (SET) process.” The same property, it added, was shared by the activated esters of amide coupling, “collectively termed redox-active esters (RAEs).” Copper followed in ACS Catalysis 2018, turning carboxylic acids into boronic esters “via redox-active esters (RAEs).”

None of this happened in isolation. Across the field, chemists were going back to old radical and redox chemistry: Okada’s electron-transfer decarboxylation, Barton’s esters and Kochi’s studies of radical pathways in nickel and iron catalysis, all decades old. What the 2016 papers added was a way of thinking and a word to go with it. An activated ester was no longer just a way to make an amide. It was an alkyl halide surrogate that a metal could reduce by one electron, without light.

Did the word catch on? The literature answers.

“Redox-active ester” enters the literature, 2000–2026

2025 143 papers say “redox-active ester”Phrase anywhere in the full text, title or abstract; research articles and reviews (OpenAlex)

2016 · “redox-active” defined 2017 · boron & alkenes 2018 · copper 0 50 100 150 200 2000: 0 papers say “redox-active ester”2001: 0 papers say “redox-active ester”2002: 0 papers say “redox-active ester”2003: 0 papers say “redox-active ester”2004: 0 papers say “redox-active ester”2005: 0 papers say “redox-active ester”2006: 0 papers say “redox-active ester”2007: 0 papers say “redox-active ester”2008: 0 papers say “redox-active ester”2009: 0 papers say “redox-active ester”2010: 0 papers say “redox-active ester”2011: 0 papers say “redox-active ester”2012: 0 papers say “redox-active ester”2013: 0 papers say “redox-active ester”2014: 0 papers say “redox-active ester”2015: 0 papers say “redox-active ester”2016: 12 papers say “redox-active ester”2017: 10 papers say “redox-active ester”2018: 22 papers say “redox-active ester”2019: 46 papers say “redox-active ester”2020: 70 papers say “redox-active ester”2021: 88 papers say “redox-active ester”2022: 100 papers say “redox-active ester”2023: 142 papers say “redox-active ester”2024: 150 papers say “redox-active ester”2025: 143 papers say “redox-active ester”2026: 191 papers say “redox-active ester” (partial year, counted on 16 November 2026) 0 20 40 60 2000: 0 per 100 papers on these esters2001: 0 per 100 papers on these esters2002: 0 per 100 papers on these esters2003: 0 per 100 papers on these esters2004: 0 per 100 papers on these esters2005: 0 per 100 papers on these esters2006: 0 per 100 papers on these esters2007: 0 per 100 papers on these esters2008: 0 per 100 papers on these esters2009: 0 per 100 papers on these esters2010: 0 per 100 papers on these esters2011: 0 per 100 papers on these esters2012: 0 per 100 papers on these esters2013: 0 per 100 papers on these esters2014: 0 per 100 papers on these esters2015: 0 per 100 papers on these esters2016: 57.1 per 100 papers on these esters2017: 29.4 per 100 papers on these esters2018: 45.8 per 100 papers on these esters2019: 50.5 per 100 papers on these esters2020: 56.5 per 100 papers on these esters2021: 54.7 per 100 papers on these esters2022: 56.2 per 100 papers on these esters2023: 55.3 per 100 papers on these esters2024: 54.5 per 100 papers on these esters2025: 49.5 per 100 papers on these esters2026: 59.9 per 100 papers on these esters (partial year, counted on 16 November 2026) 0 100 200 300 400 2000: 0 papers mention the esters2001: 0 papers mention the esters2002: 1 papers mention the esters2003: 0 papers mention the esters2004: 0 papers mention the esters2005: 0 papers mention the esters2006: 1 papers mention the esters2007: 0 papers mention the esters2008: 3 papers mention the esters2009: 3 papers mention the esters2010: 0 papers mention the esters2011: 0 papers mention the esters2012: 1 papers mention the esters2013: 1 papers mention the esters2014: 2 papers mention the esters2015: 4 papers mention the esters2016: 21 papers mention the esters2017: 34 papers mention the esters2018: 48 papers mention the esters2019: 91 papers mention the esters2020: 124 papers mention the esters2021: 161 papers mention the esters2022: 178 papers mention the esters2023: 257 papers mention the esters2024: 275 papers mention the esters2025: 289 papers mention the esters2026: 319 papers mention the esters (partial year, counted on 16 November 2026) 0 25 50 75 100 2000: 0 papers say “redox-active ester”2001: 0 papers say “redox-active ester”2002: 0 papers say “redox-active ester”2003: 0 papers say “redox-active ester”2004: 0 papers say “redox-active ester”2005: 0 papers say “redox-active ester”2006: 0 papers say “redox-active ester”2007: 0 papers say “redox-active ester”2008: 0 papers say “redox-active ester”2009: 0 papers say “redox-active ester”2010: 0 papers say “redox-active ester”2011: 0 papers say “redox-active ester”2012: 0 papers say “redox-active ester”2013: 0 papers say “redox-active ester”2014: 0 papers say “redox-active ester”2015: 0 papers say “redox-active ester”2016: 8 papers say “redox-active ester”2017: 15 papers say “redox-active ester”2018: 15 papers say “redox-active ester”2019: 39 papers say “redox-active ester”2020: 60 papers say “redox-active ester”2021: 58 papers say “redox-active ester”2022: 80 papers say “redox-active ester”2023: 70 papers say “redox-active ester”2024: 75 papers say “redox-active ester”2025: 74 papers say “redox-active ester”2026: 85 papers say “redox-active ester” (partial year, counted on 16 November 2026) 0 20 40 60 2000: 0 papers cite the 2016 paper2001: 0 papers cite the 2016 paper2002: 0 papers cite the 2016 paper2003: 0 papers cite the 2016 paper2004: 0 papers cite the 2016 paper2005: 0 papers cite the 2016 paper2006: 0 papers cite the 2016 paper2007: 0 papers cite the 2016 paper2008: 0 papers cite the 2016 paper2009: 0 papers cite the 2016 paper2010: 0 papers cite the 2016 paper2011: 0 papers cite the 2016 paper2012: 0 papers cite the 2016 paper2013: 0 papers cite the 2016 paper2014: 0 papers cite the 2016 paper2015: 0 papers cite the 2016 paper2016: 27 papers cite the 2016 paper2017: 42 papers cite the 2016 paper2018: 54 papers cite the 2016 paper2019: 52 papers cite the 2016 paper2020: 34 papers cite the 2016 paper2021: 37 papers cite the 2016 paper2022: 38 papers cite the 2016 paper2023: 23 papers cite the 2016 paper2024: 33 papers cite the 2016 paper2025: 14 papers cite the 2016 paper2026: 22 papers cite the 2016 paper (partial year, counted on 16 November 2026) 20002002200420062008201020122014201620182020202220242026
Show the numbers
YearPapers that use the termShare of NHPI-type ester papersNHPI-type esters, any nameSecond index: Europe PMCPapers citing JACS 2016
200000000
200100000
200200100
200300000
200400000
200500000
200600100
200700000
200800300
200900300
201000000
201100000
201200100
201300100
201400200
201500400
20161257.121827
20171029.4341542
20182245.8481554
20194650.5913952
20207056.51246034
20218854.71615837
202210056.21788038
202314255.32577023
202415054.52757533
202514349.52897414
2026*19159.93198522
Total974569.41,813579376

* 2026: partial year, counted on 16 November 2026.

Tap or hover over a bar to read the year; switch views with the buttons. 2026 is a partial year. Before 2016 neither OpenAlex nor Europe PMC holds a single paper that uses the phrase for this class of compounds; the four pre-2016 hits were checked by hand and all were noise.Data: OpenAlex (openalex.org) and Europe PMC (europepmc.org), queried 16 November 2026. Research articles and reviews whose indexed full text, title or abstract uses “redox-active ester(s)”; preprints, highlights and duplicate language editions excluded. Full text is indexed for only part of the literature, so every count is a lower bound, and a word count measures vocabulary, not credit. Milestones: JACS 2016; Science 2017 and Nature 2017; ACS Catal. 2018. Chart: Baran Lab website.

Before 2016 we found no paper that uses the phrase “redox-active ester” for this class of compounds. That holds in OpenAlex’s full-text index and in Europe PMC’s, two independent databases. Each index turned up a few pre-2016 hits, and on inspection every one was noise: an Elsevier record whose abstract field carries text from later papers, a vitamin E study about “non-redox active esters,” and two mis-indexed documents on road haulage and neuron models. From 2016 the curve rises almost every year: 12 papers in 2016, 70 in 2020, 143 in 2025 and 191 so far in 2026. That makes 974 in all, and these are full texts only, a fraction of the literature. About 97% of them have no author from this lab. Europe PMC, counted separately, shows the same shape: none before 2016, then 8, 60 and 74 a year.

The name did more than spread. It took over: since 2016, about half of all indexed papers that discuss NHPI-type esters, under any name, call them redox-active esters. And the chemistry itself grew. Indexed papers that mention these esters at all went from about one a year before 2016, in any context, to 289 in 2025. Counting a word measures vocabulary, not credit: the rise of these esters also owes much to photochemical and, later, electrochemical decarboxylation from many laboratories.

Graphical abstract: Practical Ni-Catalyzed Aryl–Alkyl Cross-Coupling of Secondary Redox-Active Esters
Practical Ni-catalyzed aryl–alkyl cross-coupling of secondary redox-active esters (J. Am. Chem. Soc. 2016): where the name, and its definition, began. Graphical abstract from Practical Ni-Catalyzed Aryl–Alkyl Cross-Coupling of Secondary Redox-Active Esters, J. Am. Chem. Soc. 2016 · doi:10.1021/jacs.6b00250
03 Another handle

Redox-active sulfones

Carboxylic acids were not the only abundant handle that could be turned into a radical. In 2018 the lab showed that sulfones — specifically those bearing a 1-phenyl-1H-tetrazol-5-yl (PT) group — could play a similar role, in a modular nickel-catalyzed coupling built for the saturated, fluorinated fragments medicinal chemists want.

Graphical abstract: Modular Radical Cross-Coupling with Sulfones Enables Access to sp3-rich (Fluoro)Alkylated Scaffolds
Modular radical cross-coupling with sulfones enables access to sp3-rich (fluoro)alkylated scaffolds (Science 2018). Graphical abstract from Modular Radical Cross-Coupling with Sulfones Enables Access to sp3-rich (Fluoro)Alkylated Scaffolds, Science 2018 · doi:10.1126/science.aar7335
Figure 1 of the 2018 Science paper: alkyl sulfones as modular radical precursors that can be alkylated or fluorinated before coupling; a piperidine building block that cannot be fluorinated by anionic chemistry; and the discovery that a phenyltetrazole sulfone couples with an arylzinc reagent under nickel catalysis, while ordinary aryl sulfones do not.
A, alkyl sulfones are stable, modular building blocks that can be elaborated by anionic alkylation or fluorination, or by cycloaddition, before the C–C coupling. B, the same sulfone handle lets a piperidine building block be fluorinated and then coupled — a sequence that ordinary alkyl halides and redox-active esters do not tolerate. C, the breakthrough: a phenyltetrazole (PT) sulfone delivers the coupled product in 71% isolated yield, where aryl sulfones fail; the thiol used to make the PT-sulfones is a commercial, odor-free solid.Figure 1 from Merchant, Edwards, Qin et al., “Modular radical cross-coupling with sulfones enables access to sp3-rich (fluoro)alkylated scaffolds,” Science 2018, doi:10.1126/science.aar7335. © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. Reproduced by the authors for this site.

An earlier iron-catalyzed Kumada coupling of unactivated alkyl sulfones, from Denmark and coworkers, had already shown that the functional group could take part in a cross-coupling, but the scope was narrow. The 2018 paper notes that “an ongoing medicinal chemistry project at Pfizer could have used this reaction, but the limited scope prevented its wide adoption” beyond phenylmagnesium bromide. A search for a sulfone that would reduce under mild nickel conditions found that the readily available PT-sulfones were uniquely effective. Ordinary aryl sulfones gave no product; PT-sulfone 3f delivered the coupled piperidine in 71% isolated yield. Nickel was the effective catalyst; iron was not, under the conditions examined, and a bipyridine ligand was imperative.

PT-sulfones can be made from alcohols or alkyl halides by a Mitsunobu reaction or an SN2 displacement with an inexpensive, odor-free thiol, followed by a straightforward oxidation; the products are often crystalline. The paper lists three practical advantages of the handle: it tolerates anionic chemistry (α-alkylation and fluorination) before the coupling; when the sulfone is attached to an unsaturated system, it can take part in cycloadditions and Michael/Giese-type additions; and the compounds are stable and crystalline enough to be convenient reagents. That thinking inspired five reagents, two of them new chemical entities. In collaboration with Asymchem, four of those reagents were prepared on a large scale.

The optimized conditions were illustrated in the synthesis of more than 60 products. The parent PT-sulfone was coupled with 13 different organozinc reagents, and a broad range of primary, secondary and benzylic sulfones took part. Alkyl chlorides were tolerated despite their usual readiness to engage in single-electron chemistry under nickel, a useful orthogonality. A sulfone derived from the Roche ester was coupled with no erosion of enantiomeric excess. Fluoromethyl, difluoromethyl and difluoroethyl reagents extended the method to fluoroalkyl space; bathophenanthroline was the ligand for those couplings. A current limitation, the paper is careful to state, is that a trifluoromethyl group cannot be readily installed this way.

⚗ For chemists

A Pfizer collaboration, in brief

The work was supported by Pfizer and the National Institutes of Health (grant GM-118176), and the author list includes chemists at Pfizer’s La Jolla and Groton sites. The paper’s only claim about the earlier sulfone coupling and Pfizer is the modest one quoted above: a medicinal chemistry project could have used that reaction, but the limited scope stood in the way. The 2018 method was designed to remove that barrier.

Together with redox-active esters and, later, sulfonyl hydrazides, the PT-sulfones complete a set of simple, bench-stable radical precursors drawn from everyday functional groups.

04 The next leap

Deleting redox

Every radical cross-coupling so far had a hidden requirement: someone had to supply or remove an electron. In 2026 the lab put that history on a single map and showed a way off the edge of it.

The review Simplifying Radical Cross-Coupling by Deleting Redox (Neigenfind, Kawamata & Baran, ChemRxiv 2026) sorts eighty years of coupling chemistry by where the electrons come from. Classical polar couplings need no added redox but need an organometallic partner. Redox-mediated radical couplings, whether driven by a chemical reductant, by light or by electricity, tolerate far more functional groups but need that external redox source and often special equipment. “Canonical” redox-neutral radical couplings let an organozinc or organoboron partner pay the electron, which brings the organometallic back. As the review puts it, “the fundamental requirement for external redox remained.”

Four panels arranged along a spectrum: polar couplings, redox-mediated radical couplings, canonical redox-neutral radical couplings, and sulfonyl hydrazides.
The spectrum from using redox to deleting it. Each family solves one problem and keeps another, until the reagent itself supplies both the radical and the electron.Diagram: Baran Lab website, after Figure 1 of Neigenfind, Kawamata & Baran, ChemRxiv 2026 (CC BY 4.0).

The way out is a sulfonyl hydrazide, a bench-stable, crystalline compound that can be prepared from ketones, aldehydes, amines, alcohols or alkyl halides. Under base it loses a sulfinate and then nitrogen gas, and in doing so delivers both an alkyl radical and the electron the nickel catalyst needs. The reagent is its own reductant. Reported in 2024 and fully elaborated in Science in 2025, the platform works with nickel, cobalt, iron and copper catalysts in what the authors call “dump-and-stir” reactions.

Reaction scheme: an alkyl sulfonyl hydrazide loses a sulfinate to form a diazene (R–N=N–H), which binds nickel and loses nitrogen gas to give an alkyl radical that couples to an aryl group.
Loss of N₂, one of the most stable molecules there is, pays for the electron transfer.Diagram: Baran Lab website, after the working hypothesis in Figure 4D of Sun, Péter, He et al., Science 2025, doi:10.1126/science.adu6406.

“The advantage of a dump-and-stir reaction is that when you scale it up, you don’t need specialized equipment.”

⚗ For chemists

Inside the mechanism

In the original Science study, a mild base liberates a diazene (R–N=N–H) from the sulfonyl hydrazide. The diazene associates to a high-spin Ni(II) complex in a Z configuration; after a nearly thermoneutral deprotonation, extrusion of N₂ has only a modest barrier (ΔG‡ ≈ 5 kcal mol⁻¹) and gives the alkyl radical and Ni(I). Oxidative addition of the aryl halide and radical capture follow. Later kinetic and computational work, summarised in the review, describes these as “nested rather than sequential” cycles. Because the departing sulfinate controls the rate of α-elimination, changing its aryl substituents tunes radical release about 100-fold (k = 0.03 min⁻¹ for p-OMe to 3.5 min⁻¹ for 3,5-diF at 330 K): a “traceless kinetics directing group.”

The most surprising result came next. Free radicals lose their 3D shape in picoseconds, so a coupling that keeps a stereocentre intact was, in the words of the lab’s 2025 preprint, “generally believed to be impossible.” In Nature in 2025 the lab reported the first stereoretentive radical cross-couplings: an enantioenriched sulfonyl hydrazide and an achiral nickel catalyst give products with enantiospecificity averaging 86–91% and up to 95%. A 2026 Science paper extended the idea to alkyl–alkyl bonds after screening roughly 1,000 conditions, reaching 80–96% e.s. The full story is told in Thinking in radicals.

Graphical abstract: Stereoretentive Radical Cross-Coupling
Stereoretentive radical cross-coupling (Nature 2025): the radical forms and bonds before it can scramble its shape, guided by a nickel-bound diazene. Graphical abstract from Stereoretentive Radical Cross-Coupling, Nature 2025 · doi:10.1038/s41586-025-09011-0
05 Case study

Sugars, without the protecting groups

Gliflozins such as dapagliflozin and empagliflozin are diabetes drugs with a sugar joined to an aromatic ring through a carbon–carbon bond, a C-glycoside. The figure below, from the lab’s 2026 Nature paper, puts their market sizes at about US$8 billion and US$13 billion. The usual route protects the sugar, adds an organometallic at very low temperature, and then reduces and deprotects.

Figure 1 of the Nature 2026 C-glycoside paper: approved C-aryl glycoside drugs, previous one- and two-electron approaches, and the glycohydrazide approach.
a, C-aryl glycoside drugs and the conventional route. b, earlier one- and two-electron strategies and the radical precursors they required. c, glycohydrazides made directly from unprotected sugars and coupled with nickel.Figure 1 from Guo, Li, Buchberger et al., “C-Glycoside Synthesis via Radical Cross-Coupling of Glycohydrazides,” Nature 2026, doi:10.1038/s41586-026-10807-x. © The Authors, licensed under CC BY 4.0. Reproduced unchanged.

Native, unprotected sugars condense directly with an aryl sulfonyl hydrazine to give glycohydrazides, on decagram scale. With nickel, these couple to aryl halides, and the review reports that nearly all FDA-approved gliflozins can be made in a single cross-coupling step, replacing routes of 4 to 19 steps.

A short film from the lab on glycohydrazide chemistry. Baran Lab · Watch on YouTube ↗
06 Why it matters

Boring reactions, on purpose

The test of a method in this lab is whether someone else uses it. Many of the papers above were written with medicinal and process chemists at Pfizer, Bristol Myers Squibb and other companies as co-authors; the 2025 Science paper on sulfonyl hydrazides is one. Industry points the lab at problems that matter, such as the C(sp³)-rich, three-dimensional fragments drug hunters want but cannot easily make.

Decarboxylative coupling also helped build a company. Vividion Therapeutics began at Scripps Research in 2014 as a collaboration between Phil Baran, Ben Cravatt and Jin-Quan Yu, its three co-founders. The company pairs the Cravatt lab’s chemoproteomic profiling, which maps where small molecules bind across thousands of proteins, with a custom library of covalent compounds that, in the words of its 2021 registration statement, is “uniquely enabled by advanced chemistry developed by Drs. Baran and Yu.” According to Phil Baran, decarboxylative cross-coupling was one of the main methods used to build that chemistry when Vividion was starting out. The collaboration continues: a 2026 preprint with Vividion scientists uses decarboxylative cross-coupling and sulfonyl hydrazides to make every possible regio- and stereoisomer of a set of piperidine and pyrrolidine probes for chemoproteomic screening.

On 5 August 2021, Bayer announced that it would acquire Vividion for US$1.5 billion upfront and up to $500 million in success-based milestone payments. The deal closed on 19 August 2021, and Vividion continues to operate as an independent subsidiary.

Bayer announcement, 5 August 2021

“Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics.”

Read the press release ↗
600+products from sulfonyl hydrazide couplings and additions
14ready-made fragments in the 2025 toolbox, from methyl to oxetane
~1,000conditions screened for stereoretentive alkyl–alkyl coupling

“Our lab aims to invent boring reactions. The boring reactions are the best.”

Phil’s talk for Drug Hunter on what radical cross-coupling means for medicinal chemistry. The video starts at the beginning of the talk. Drug Hunter · recorded 26 Jun 2025 · starts at 12:27 · Watch on YouTube ↗

Try the reagents

Sulfonyl hydrazides, sulfinates and redox-active esters are sold by several suppliers. The reagents deep dive lists them.

Reagents deep dive →
07 Where it’s going

Toward a radical Suzuki

The 2026 review ends with a to-do list: carbon–nitrogen, carbon–oxygen and carbon–fluorine bonds; tertiary and acyl sulfonyl hydrazides; kilogram-scale preparation. Its ambition is a coupling with “operational ease akin to the venerable Suzuki coupling,” but for the saturated, three-dimensional carbon frameworks that the Suzuki reaction handles poorly.

“They would establish a new bond-forming logic in which radical generation is intrinsic to the reagent itself.”

— Neigenfind, Kawamata & Baran, “Simplifying Radical Cross-Coupling by Deleting Redox,” ChemRxiv 2026

The planning logic behind these couplings, and the map from using redox to deleting it, is told in radical retrosynthesis: the logic. A parallel line uses olefins as radical donors: reductive olefin cross-coupling. Electrochemistry is the other half of this story: many radical couplings are driven by electrons from an electrode. Continue with Electrochemistry, made practical, or see the methods at work in total synthesis.

Go deeper

Key reading

Reviews and essential papers, picked as a path into the field.

Start here

Simplifying Radical Cross-Coupling by Deleting Redox

Neigenfind, P.; Kawamata, Y.; Baran, P. S. · ChemRxiv 2026 · Open access

Radicals: Reactive Intermediates with Translational Potential

Yan, M.; Lo, J. C.; Edwards, J. T. et al. · J. Am. Chem. Soc. 2016

Related papers

All lab papers tagged Cross-coupling